Discovery of Antagonists of GPR35, a Genetically Validated Target in Gastrointestinal Diseases
Time: 12:00 pm
day: Conference Day One
Details:
- GPR35 is a genetically validated target in gastrointestinal diseases
- A drug discovery program led to the identification of small molecules with strong pharmacological validation
- A preclinical candidate has been nominated for clinical development
